SCHEMBL17849207

SCHEMBL17849207

N=C(c1ccc(N2CCOCC2)cc1)c1c(Nc2c(F)cccc2F)c(Br)c[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK1 Q13464 1/20 0.39
CCNT1 O60563 1/20 0.36
CCNE1 P24864 1/20 0.36
CDK2 P24941 1/20 0.36
CDK9 P50750 1/20 0.36
ZAP70 P43403 1/20 0.36
MAPT P10636 5/20 0.35
GSK3B P49841 1/20 0.35
RAF1 P04049 1/20 0.35
BRAF P15056 1/20 0.35
ALDH1A1 P00352 3/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
HDAC8 Q9BY41 2/20 0.35
HDAC6 Q9UBN7 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16623587 0.89 ROCK1 (0.39) ROCK1CCNT1CCNE1CDK2CDK9
SCHEMBL17849219 0.89 RAF1 (0.42) ROCK1CCNT1CCNE1CDK2CDK9
SCHEMBL17849203 0.87 ROCK1 (0.40) ROCK1CCNT1CCNE1CDK2CDK9
SCHEMBL17849214 0.86 TYK2 (0.38) ROCK1CCNT1CCNE1CDK2CDK9
SCHEMBL17849188 0.82 EGFR (0.40) ROCK1CCNT1CCNE1CDK2CDK9
SCHEMBL17849217 0.80 DGAT1 (0.33) ROCK1MAPTALDH1A1MEN1KMT2A
SCHEMBL17849202 0.79 SMN1; SMN2 (0.44) MAPTALDH1A1NPC1RAB9AMEN1
SCHEMBL17849189 0.77 RAB9A (0.45) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL16623518 0.77 KMT2A (0.31) KMT2A
SCHEMBL16623486 0.75 TAAR1 (0.32) RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed